JINS HOLDINGS Inc. (JNDOF)
USD 22.75
(0.0%)
USD 22.75
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 44.85 Billion JPY | -18.02% |
| 2022 | 54.71 Billion JPY | 3.24% |
| 2021 | 53 Billion JPY | -0.72% |
| 2020 | 53.38 Billion JPY | 45.77% |
| 2019 | 36.62 Billion JPY | 16.29% |
| 2018 | 31.49 Billion JPY | 3.77% |
| 2017 | 30.35 Billion JPY | 15.73% |
| 2016 | 26.22 Billion JPY | 6.34% |
| 2015 | 24.66 Billion JPY | 18.63% |
| 2014 | 20.78 Billion JPY | -3.82% |
| 2013 | 21.61 Billion JPY | 34.75% |
| 2012 | 16.04 Billion JPY | 138.21% |
| 2011 | 6.73 Billion JPY | 50.63% |
| 2010 | 4.47 Billion JPY | 7.3% |
| 2009 | 4.16 Billion JPY | 22.06% |
| 2008 | 3.41 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 44.94 Billion JPY | 0.21% |
| 2024 Q3 | 48.66 Billion JPY | 4.69% |
| 2024 Q2 | 46.48 Billion JPY | 3.42% |
| 2023 Q2 | 42.54 Billion JPY | -21.57% |
| 2023 Q3 | 44.45 Billion JPY | 4.49% |
| 2023 Q4 | 44.85 Billion JPY | 0.91% |
| 2023 FY | 44.85 Billion JPY | -18.02% |
| 2023 Q1 | 54.24 Billion JPY | -0.86% |
| 2022 Q4 | 54.71 Billion JPY | 0.72% |
| 2022 FY | 54.71 Billion JPY | 3.24% |
| 2022 Q1 | 52.68 Billion JPY | -0.6% |
| 2022 Q3 | 54.32 Billion JPY | 0.63% |
| 2022 Q2 | 53.99 Billion JPY | 2.48% |
| 2021 Q3 | 51.99 Billion JPY | -2.25% |
| 2021 Q4 | 53 Billion JPY | 1.94% |
| 2021 Q1 | 51.25 Billion JPY | -3.99% |
| 2021 FY | 53 Billion JPY | -0.72% |
| 2021 Q2 | 53.18 Billion JPY | 3.76% |
| 2020 FY | 53.38 Billion JPY | 45.77% |
| 2020 Q1 | 34.98 Billion JPY | -4.47% |
| 2020 Q4 | 53.38 Billion JPY | 7.09% |
| 2020 Q3 | 49.85 Billion JPY | -13.28% |
| 2020 Q2 | 57.48 Billion JPY | 64.3% |
| 2019 Q2 | 31.61 Billion JPY | -3.17% |
| 2019 Q3 | 34.75 Billion JPY | 9.95% |
| 2019 Q4 | 36.62 Billion JPY | 5.38% |
| 2019 Q1 | 32.64 Billion JPY | 3.65% |
| 2019 FY | 36.62 Billion JPY | 16.29% |
| 2018 FY | 31.49 Billion JPY | 3.77% |
| 2018 Q2 | 29.64 Billion JPY | -3.7% |
| 2018 Q3 | 31.14 Billion JPY | 5.06% |
| 2018 Q4 | 31.49 Billion JPY | 1.12% |
| 2018 Q1 | 30.78 Billion JPY | 1.44% |
| 2017 Q4 | 30.35 Billion JPY | 4.56% |
| 2017 Q1 | 25.35 Billion JPY | -3.32% |
| 2017 Q2 | 27.35 Billion JPY | 7.88% |
| 2017 Q3 | 29.02 Billion JPY | 6.12% |
| 2017 FY | 30.35 Billion JPY | 15.73% |
| 2016 FY | 26.22 Billion JPY | 6.34% |
| 2016 Q4 | 26.22 Billion JPY | 2.03% |
| 2016 Q3 | 25.7 Billion JPY | 1.13% |
| 2016 Q2 | 25.41 Billion JPY | 3.72% |
| 2016 Q1 | 24.5 Billion JPY | -0.64% |
| 2015 Q1 | 20.96 Billion JPY | 0.85% |
| 2015 FY | 24.66 Billion JPY | 18.63% |
| 2015 Q2 | 21.41 Billion JPY | 2.15% |
| 2015 Q3 | 23.54 Billion JPY | 9.96% |
| 2015 Q4 | 24.66 Billion JPY | 4.72% |
| 2014 Q4 | 20.78 Billion JPY | 1.84% |
| 2014 FY | 20.78 Billion JPY | -3.82% |
| 2014 Q3 | 20.41 Billion JPY | 4.92% |
| 2014 Q2 | 19.45 Billion JPY | -2.16% |
| 2014 Q1 | 19.88 Billion JPY | -8.01% |
| 2013 Q2 | 20 Billion JPY | 19.18% |
| 2013 Q3 | 21.5 Billion JPY | 7.5% |
| 2013 Q4 | 21.61 Billion JPY | 0.5% |
| 2013 Q1 | 16.78 Billion JPY | 4.65% |
| 2013 FY | 21.61 Billion JPY | 34.75% |
| 2012 Q4 | 16.04 Billion JPY | 68.65% |
| 2012 Q2 | 8.03 Billion JPY | 12.81% |
| 2012 Q1 | 7.12 Billion JPY | 5.81% |
| 2012 Q3 | 9.51 Billion JPY | 18.33% |
| 2012 FY | 16.04 Billion JPY | 138.21% |
| 2011 FY | 6.73 Billion JPY | 50.63% |
| 2011 Q3 | 5.86 Billion JPY | 15.53% |
| 2011 Q4 | 6.73 Billion JPY | 14.77% |
| 2011 Q1 | 5.06 Billion JPY | 13.28% |
| 2011 Q2 | 5.07 Billion JPY | 0.29% |
| 2010 FY | 4.47 Billion JPY | 7.3% |
| 2010 Q4 | 4.47 Billion JPY | 6.02% |
| 2010 Q3 | 4.21 Billion JPY | 0.0% |
| 2009 Q4 | 4.16 Billion JPY | 0.0% |
| 2009 Q1 | 4.09 Billion JPY | 0.0% |
| 2009 Q2 | 4.45 Billion JPY | 8.61% |
| 2009 FY | 4.16 Billion JPY | 22.06% |
| 2008 FY | 3.41 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | -2440299.116% |
| Ansell Limited | 3.23 Billion USD | -1285.928% |
| Ansell Limited | 3.24 Billion USD | -1283.334% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | -9073.22% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -14933879.665% |
| Psykey, Inc. | 1.72 Million USD | -2596695.109% |
| ConvaTec Group Plc | 3.7 Billion USD | -1109.56% |
| ConvaTec Group Plc | 3.71 Billion USD | -1107.852% |
| Encision Inc. | 3.81 Million USD | -1177001.626% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -6880910.491% |
| LifePoint, Inc. | 8.8 Million USD | -509096.609% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | -281023.088% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -5011743.575% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | -817091.631% |
| Reflect Scientific, Inc. | 2.66 Million USD | -1680590.531% |
| SmileDirectClub, Inc. | 597.06 Million USD | -7412.775% |
| Sector 10, Inc. | 1000.00 USD | -4485599900.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | -845.09% |
| SheerVision, Inc. | 837.56 Thousand USD | -5355424.646% |
| United Health Products, Inc. | 284.64 Thousand USD | -15758587.198% |
| Vasamed, Inc. | 1.6 Million USD | -2802974.283% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -20099105.549% |
| Yubo International Biotech Limited | 2.34 Million USD | -1909843.621% |